- Investing Ideas
- /
- Taiwanese Pharmaceuticals & Biotech Sustainable Track Record
Taiwanese Pharmaceuticals & Biotech Sustainable Track Record
Results
4
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
4 companies
PharmaEngine
Market Cap: NT$13.0b
A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.
4162
NT$90.30
7D
-2.3%
1Y
-0.3%
TTY Biopharm
Market Cap: NT$18.7b
Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.
4105
NT$75.20
7D
0.1%
1Y
-3.1%
Lotus Pharmaceutical
Market Cap: NT$61.5b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$234.50
7D
3.3%
1Y
-17.4%
Bora Pharmaceuticals
Market Cap: NT$79.5b
Researches and develops, manufactures, distributes, and sells pharmaceuticals worldwide.
6472
NT$770.00
7D
-1.0%
1Y
0.8%